David Mark Hodges, M.D.,

NPI 1881734168ActiveIndividual· Internal Medicine, Cardiovascular Disease· Englewood, NJ

Internal Medicine, Cardiovascular Disease (M.D.,) in Englewood, New Jersey, trained at New York University School of Medicine (class of 1984). Their prescriptions cost Medicare Part D more than their services did: $164,194 for 1,221 claims, against $21,566 paid for services in 2024. Novo Nordisk Inc was the largest of 8 companies reporting payments in 2025, $349.57 in all, mostly food and beverage.

Overview

NPI	1881734168
Status	Active
Entity type	Individual
Credential	M.D.,
Sole proprietor	Yes
NPI issued	Feb 7, 2007
Last updated in NPPES	Feb 19, 2008

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Cardiovascular Disease Primary	207RC0000X	25MA06210000	NJ

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Cardiovascular Disease (Cardiology) (NJ)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	82
Services billed	413 across 10 procedure codes
Paid by Medicare	$21,566

Part D prescriptions in 2024

Prescriptions (claims)	1,221 · 3,066 30-day fills
Patients	125
Total drug cost	$164,194
Generic share	87% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York University School of Medicine
Graduation year	1984
Medicare specialty	Cardiovascular Disease (Cardiology)
Secondary specialties	Internal Medicine